Diclofenac Sodium Tablet, Delayed Release
Product Images NDC 51655-280

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diclofenac Sodium (NDC 51655-280). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Dic05 0006 01)

Chemical structure of Diclofenac Sodium, showing two chlorinated benzene rings linked by a nitrogen atom with an acetic acid side chain. The structure represents the active ingredient in Diclofenac Sodium Delayed Release tablets.*

FDA Label Image

Dic05-0006-03 (Dic05 0006 03)

Diclofenac Sodium Delayed Release 50 mg oral tablets in a blister pack by Northwind Health Company, LLC. The pack contains multiple white, round tablets arranged in a single row within a clear plastic and foil blister strip.*

FDA Label Image

Label (51655 280 52 Rev A 10 22 Nhc)

Label for Diclofenac Sodium Delayed Release Tablets USP, 50 mg, oral dosage form, containing 30 tablets. The label shows the product NDC 51655-280-52, prescription-only status, storage instructions, manufacturer as Northwind Health Company, LLC, and batch-related identifiers including NDC barcode and lot information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.